BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND FLT4, FLT41, 2324, ENSG00000037280, P35916, VEGFR3, PCL
94 results:

  • 1. A Homodimer of Withaferin A Formed by Base-Promoted Elimination of Acetic Acid from 27-
    Wijeratne EMK; Xu YM; Padumadasa C; Astashkin AV; Gunatilaka AAL
    J Nat Prod; 2024 Mar; 87(3):583-590. PubMed ID: 38414352
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Bone mimetic environments support engineering, propagation, and analysis of therapeutic response of patient-derived cells, ex vivo and in vivo.
    Paindelli C; Parietti V; Barrios S; Shepherd P; Pan T; Wang WL; Satcher RL; Logothetis CJ; Navone N; Campbell MT; Mikos AG; Dondossola E
    Acta Biomater; 2024 Apr; 178():83-92. PubMed ID: 38387748
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting prostate cancer with docetaxel-loaded peptide 563-conjugated PEtOx-co-PEI
    Nezir AE; Bolat ZB; Ozturk N; Kocak P; Zemheri E; Gulyuz S; Ozkose UU; Yilmaz O; Vural I; Bozkır A; Sahin F; Telci D
    Amino Acids; 2023 Aug; 55(8):1023-1037. PubMed ID: 37318626
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs.
    Shirvaliloo M
    Epigenomics; 2023 Jan; 15(2):61-73. PubMed ID: 36802727
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nanoencapsulation of R-phycoerytrin extracted from
    Pereira Martins JR; Linhares de Aguiar AL; Barros Nogueira KA; Uchôa Bastos Filho AJ; da Silva Moreira T; Lima Holanda Araújo M; Pessoa C; Eloy JO; da Silva Junior IJ; Petrilli R
    J Microencapsul; 2023 Jan; 40(1):37-52. PubMed ID: 36630267
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Preparing Future Medicine Physicians to Care for cancer Survivors: Project ECHO® in a Novel Internal Medicine and Family Medicine Residency Curriculum.
    Choi Y; Chodoff AC; Brown K; Murillo LA; Nesfeder J; Bugayong MT; Peairs KS
    J Cancer Educ; 2023 Apr; 38(2):608-617. PubMed ID: 35366218
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Polymeric Nanoparticles for the Treatment of prostate cancer- Technological Prospecting and Critical Analysis.
    de Oliveira CR; Droppa-Almeida D; Padilha FF; de Souza RR; de Albuquerque-Júnior RLC
    Recent Pat Nanotechnol; 2023; 17(1):8-14. PubMed ID: 35100962
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Inflammatory markers in women with reported benign gynecologic pathology: an analysis of the prostate, Lung, Colorectal and Ovarian cancer Screening Trial.
    King LA; Wentzensen N; Purdue MP; Katki HA; Pinto LA; Trabert B
    Ann Epidemiol; 2022 Apr; 68():1-8. PubMed ID: 34906633
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Reactive oxygen species and glutathione dual responsive nanoparticles for enhanced prostate cancer therapy.
    Zhang L; Zhang S; Li M; Li Y; Xiong H; Jiang D; Li L; Huang H; Kang Y; Pang J
    Mater Sci Eng C Mater Biol Appl; 2021 Apr; 123():111956. PubMed ID: 33812584
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Targeted micelles with chemotherapeutics and gene drugs to inhibit the G1/S and G2/M mitotic cycle of prostate cancer.
    Zhang Y; Wang Y; Meng L; Huang Q; Zhu Y; Cui W; Cheng Y; Liu R
    J Nanobiotechnology; 2021 Jan; 19(1):17. PubMed ID: 33422073
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Differences in Genomic Alterations Between Brain Metastases and Primary Tumors.
    Dono A; Takayasu T; Yan Y; Bundrant BE; Arevalo O; Lopez-Garcia CA; Esquenazi Y; Ballester LY
    Neurosurgery; 2021 Feb; 88(3):592-602. PubMed ID: 33369669
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Utilization of Poly(2-ethyl-2-oxazoline)-b-Poly(ε-caprolactone) Ellipsoidal Particles for Intracellular BIKDDA Delivery to prostate cancer.
    Kocak P; Oz UC; Bolat ZB; Ozkose UU; Gulyuz S; Tasdelen MA; Yilmaz O; Bozkir A; Sahin F; Telci D
    Macromol Biosci; 2021 Feb; 21(2):e2000287. PubMed ID: 33191572
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.
    Gautam N; Kaur M; Kaur S
    J Cancer Res Ther; 2021; 17(2):311-326. PubMed ID: 33063698
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Cell Membrane-Inspired Polymeric Vesicles for Combined Photothermal and Photodynamic prostate cancer Therapy.
    Hu J; Luo H; Qu Q; Liao X; Huang C; Chen J; Cai Z; Bao Y; Chen G; Li B; Cui W
    ACS Appl Mater Interfaces; 2020 Sep; 12(38):42511-42520. PubMed ID: 32897691
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Nanoencapsulation of triterpene 3β,6β,16β-trihydroxylup-20(29)-ene from Combretum leprosum as strategy to improve its cytotoxicity against cancer cell lines.
    Silva-Filho CJA; Freitas PGC; Oliveira FCE; Barbosa FG; Oliveira MCF; Eloy JO; Pessoa C; Mafezoli J
    Bioorg Med Chem Lett; 2020 Oct; 30(20):127469. PubMed ID: 32768650
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Analysis of the concordance of 20 immunohistochemical tissue markers in metastasectomy lesions in patients with metastatic renal cell carcinoma: A retrospective study using tissue microarray.
    Kim SH; Park WS; Park EY; Joo J; Chung J
    Investig Clin Urol; 2020 Jul; 61(4):372-381. PubMed ID: 32665993
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Characterization and in vitro antitumor activity of polymeric nanoparticles loaded with Uncaria tomentosa extract.
    Ribeiro AF; Santos JF; Mattos RR; Barros EGO; Nasciutti LE; Cabral LM; Sousa VP
    An Acad Bras Cienc; 2020; 92(1):e20190336. PubMed ID: 32321026
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Post-HIFU locally relapsed prostate cancer: high-dose salvage radiotherapy guided by molecular imaging.
    Rigo M; Mazzola R; Napoli G; Giaj-Levra N; Figlia V; Nicosia L; Ricchetti F; Tomasini D; Bonù ML; Cuccia F; Bellorofonte C; Alongi F
    Radiol Med; 2020 May; 125(5):491-499. PubMed ID: 32077006
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Three novel methods to measure the postoperative displacement of lower urinary tract structures following radical prostatectomy in a sample of Korean patients.
    Ha HK; Luiting HB; Graham PL; Patel MI; Sandhu JS; Akin O; Mungovan SF
    BMC Urol; 2019 Jun; 19(1):54. PubMed ID: 31215416
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. KLK3/PSA and cathepsin D activate VEGF-C and VEGF-D.
    Jha SK; Rauniyar K; Chronowska E; Mattonet K; Maina EW; Koistinen H; Stenman UH; Alitalo K; Jeltsch M
    Elife; 2019 May; 8():. PubMed ID: 31099754
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.